Skip to content
healthcare.dev

MERCAPTOPURINE

NDC 62484-1020, MERCAPTOPURINE, suspension, from Nova Laboratories, Ltd.

Product NDC
62484-1020
Status
Listed
Labeler
Nova Laboratories, Ltd
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA205919
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62484-1020 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MERCAPTOPURINE20 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
62484-1020-4624841020041 BOTTLE in 1 CARTON (62484-1020-4) / 100 mL in 1 BOTTLE (62484-1020-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9c6fc66b-522f-499d-961a-cde6ca0ec2e5

Use it

Look up 62484-1020 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62484-1020 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62484-1020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.